Novartis AG (NVS): Price and Financial Metrics
Novartis AG (NVS)
Today's Latest Price: $92.80 USD
0.27 (0.29%)
Updated Dec 10 4:10pm
Add NVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NVS Stock Summary
- NVS has a higher market value than 99.35% of US stocks; more precisely, its current market capitalization is $203,221,303,752.
- With a year-over-year growth in debt of 57.5%, Novartis Ag's debt growth rate surpasses 80.93% of about US stocks.
- In terms of volatility of its share price, NVS is more volatile than merely 13.46% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Novartis Ag are CSCO, PFE, ORCL, MRK, and BA.
- NVS's SEC filings can be seen here. And to visit Novartis Ag's official web site, go to www.novartis.com.
NVS Daily Price Range
NVS 52-Week Price Range
NVS Stock Price Chart More Charts
NVS Price/Volume Stats
| Current price | $92.80 | 52-week high | $95.00 |
| Prev. close | $92.53 | 52-week low | $72.19 |
| Day low | $92.28 | Volume | 1,702,531 |
| Day high | $92.86 | Avg. volume | 2,140,879 |
| 50-day MA | $88.52 | Dividend yield | 1.99% |
| 200-day MA | $86.80 | Market Cap | 212.68B |
Novartis AG (NVS) Company Bio
Novartis AG offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology and dermatology, retina, respiratory, neuroscience, and established medicines. The company was founded in 1895 and is based in Basel, Switzerland.
Top Stories View All
Why Investors Should be Bullish About GW Pharmaceuticals (GWPH)
Why I Believe Facebook (FB) is Headed Higher
Best & Worst Performing Stock Industries for December 10, 2019
Best & Worst Performing Small Cap Stocks for December 10, 2019
Best & Worst Performing Mid Cap Stocks for December 10, 2019
View All Top Stories
Loading social stream, please wait...